Package 62559-265-30

Brand: tranexamic acid

Generic: tranexamic acid
NDC Package

Package Facts

Identity

Package NDC 62559-265-30
Digits Only 6255926530
Product NDC 62559-265
Description

30 TABLET in 1 BOTTLE (62559-265-30)

Marketing

Marketing Status
Marketed Since 2021-07-01
Brand tranexamic acid
Generic tranexamic acid
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "edec7ff1-1b0a-414b-a719-e65376c7034b", "openfda": {"nui": ["N0000175634", "N0000175632"], "upc": ["0362559265300"], "unii": ["6T84R30KC1"], "rxcui": ["883826"], "spl_set_id": ["82bc4879-bcf5-47c4-8636-a73c4e7d0de9"], "pharm_class_pe": ["Decreased Fibrinolysis [PE]"], "pharm_class_epc": ["Antifibrinolytic Agent [EPC]"], "manufacturer_name": ["ANI Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (62559-265-30)", "package_ndc": "62559-265-30", "marketing_start_date": "20210701"}], "brand_name": "Tranexamic Acid", "product_id": "62559-265_edec7ff1-1b0a-414b-a719-e65376c7034b", "dosage_form": "TABLET", "pharm_class": ["Antifibrinolytic Agent [EPC]", "Decreased Fibrinolysis [PE]"], "product_ndc": "62559-265", "generic_name": "Tranexamic Acid", "labeler_name": "ANI Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tranexamic Acid", "active_ingredients": [{"name": "TRANEXAMIC ACID", "strength": "650 mg/1"}], "application_number": "ANDA203256", "marketing_category": "ANDA", "marketing_start_date": "20210701", "listing_expiration_date": "20261231"}